Edison Issues Report on Trade Estates REIC (TRESTATES)
London, United Kingdom--(Newsfile Corp. - July 30, 2026) - Edison issues report on Trade Estates REIC (ATSE: TRESTATES). Trade Estates REIC (TRESTATES) offers focused exposure to modern retail parks and new-generation logistics assets in Greece, Cyprus and Bulgaria. Demand for both sectors is driven by structural growth trends in retail spending, and both sectors are undersupplied. In Greece, Trade Estates is dominant in modern retail parks, where active management and deep sector exper
Services bancaires / financiers, Matériel informatique, Logiciels, Santé
2026-07-30 11:21 AM EDT | Edison Group
Edison Issues Report on Fourlis Holdings (FOYRK)
London, United Kingdom--(Newsfile Corp. - July 30, 2026) - Edison issues report on Fourlis Holdings (ATSE: FOYRK). Fourlis Holdings is a leading Southeast European retailer operating exclusive long-term franchise and licence agreements with brands such as IKEA, INTERSPORT and Foot Locker, combining their global brand strength with the group's deep local market expertise. The partnerships provide exposure to product categories with favourable growth profiles, including home furnishings,
Services bancaires / financiers, Matériel informatique, Logiciels, Santé
2026-07-30 10:29 AM EDT | Edison Group
Therma Bright Inc. Completes Debt Settlements
Toronto, Ontario--(Newsfile Corp. - July 30, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma" or the "Company"), a developer and investment partner specializing in advanced medical device technologies, announces that further to its press release of June 23, 2026, it has now issued an aggregate of 6,613,999 common shares at a deemed price of $0.06 per share to settle aggregate debt of $396,840. All shares issued in relation to these debt settlements a
Technologies, Biotechnologies, Santé
2026-07-30 8:16 AM EDT | Therma Bright Inc.
Delota Reports Financial Results for the Year Ended March 31, 2026
Highlights: Total revenue of $34.8 million for the Year Ended 2026 Total System-Wide Revenue of $39.8 million for the Year Ended 2026 33% gross profit margin for the Year Ended 2026 Segmented revenue for the Year Ended 2026: Vape - B2C: $19.8 million, B2B: $11.1 million Cannabis - B2C: $3.9 million Launched 180 Smoke V
Commerce de détail, Cannabis, Santé, Dispensaires de cannabis
2026-07-30 7:30 AM EDT | Delota Corp.
TempraMed Uplists to OTCQB Venture Market and Achieves DTC Eligibility, Expanding Access to U.S. Investors
Toronto, Ontario--(Newsfile Corp. - July 30, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (OTCQB: TMPTF) (FSE: 9DY) ("TempraMed" or the "Company") is pleased to announce that its common shares have been approved to commence trading on the OTCQB Venture Market, operated by OTC Markets Group Inc. The Company's shares are also now DTC eligible, significantly enhancing the accessibility and efficiency of trading for U.S. investors. Tempra
Technologies, Biotechnologies, Pharmaceutique, Santé
2026-07-30 7:00 AM EDT | TempraMed Technologies Ltd.
Psyched Wellness Launches Strategic Review to Unlock Shareholder Value
Toronto, Ontario--(Newsfile Corp. - July 29, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) ("Psyched Wellness" or the "Company"), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, announces that its Board of Directors has commenced a strategic review process designed to evaluate opportunities to enhance and accelerate value creation for shareholders ("Strategic Review").
Cannabis, Santé, Psychédéliques, Producteurs de cannabis
2026-07-29 5:42 PM EDT | Psyched Wellness Ltd.
Tersis Technologies Appoints Plastics Recycling Veteran Paul Vanderpool as Strategic Advisor to PolyCycle
Brooksville, Florida--(Newsfile Corp. - July 29, 2026) - Tersis Technologies, Inc. (OTCID: TERS) ("Tersis" or the "Company"), a clean technology company focused on transforming waste streams into valuable resources, today announced the appointment of plastics recycling veteran Paul Vanderpool as Strategic Advisor to PolyCycle™, the Company's plastics recycling and remanufacturing division.
Agriculture, Énergie, Énergies de substitution, Santé
2026-07-29 11:16 AM EDT | Tersis Technologies Inc.
Visionary Holdings' Subsidiary Nanjing Tuoyuanjian Health Technology Co., Ltd. Enters into Distribution Agreement with Suncare (Shanghai) Health Technology Co., Ltd.
Nanjing, China--(Newsfile Corp. - July 29, 2026) - Visionary Holdings Inc. (NASDAQ: GV) ("Visionary" or the "Company") today announced that its subsidiary, Nanjing Tuoyuanjian Health Technology Co., Ltd. ("GV Nanjing"), has entered into a Distribution Agreement with Suncare (Shanghai) Health Technology Co., Ltd. ("Suncare"), an AI-driven digital health and community-based senior care platform in China. Under the Distribution Agreement, GV Nanjing will supply stem cell aesthetic products
2026-07-29 9:30 AM EDT | Visionary Holdings Inc.
BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference
British Columbia and Rehovot, Israel--(Newsfile Corp. - July 29, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that its Chief Executive Officer, Zaki Rakib, will present at the upcoming Canaccord Genuity 46th Annual Growth Conference, to be held on August 11-13, 2026, in Boston, Massachusetts. In ad
Biotechnologies, Pharmaceutique, Santé
2026-07-29 8:00 AM EDT | BioHarvest Sciences Inc.
Red Light Holland Reports Fiscal 2026 Audited Year-End Results and Provides Update on Rhelion Life Sciences
Toronto, Ontario--(Newsfile Corp. - July 29, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based organization advancing innovation and research within the legal psychedelic sector, is pleased to report its audited annual consolidated financial statements and management's discussion and analysis ("MD&A") for the fiscal years ended March 31, 2026 and 2025. All figures are reported in Canadian dol
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-07-29 7:53 AM EDT | Red Light Holland Corp.
Adia Med Completes Phase 1 and Formally Launches Phase 2 of Autism Spectrum Disorder Clinical Study
Winter Park, Florida--(Newsfile Corp. - July 29, 2026) - Adia Med Inc. (OTCQB: ADIA) today announced two distinct milestones in its Autism Spectrum Disorder (ASD) clinical research study (ClinicalTrials.gov Identifier: NCT07304440): the completion of Phase 1 treatment for the study's first cohort of children, and the formal launch of Phase 2 of the study. Separately, the company confirmed that a new cohort of 30 children will begin its own Phase 1 treatment on October 1, 2026, as part of the
Soins de santé et hôpitaux, Santé
2026-07-29 6:00 AM EDT | Adia Med Inc.
Restart Life Sciences Announces Strategic Focus on Targeted M&A Expansion in Health and CPG Sectors
Vancouver, British Columbia--(Newsfile Corp. - July 29, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to provide a corporate update on its strategic growth initiatives as the Company actively pursues targeted merger and acquisition opportunities to further expand its presence in the health and wellness segments of the consumer packaged goods sector. Following the acquisition and successful operational rollout o
Technologies, Biotechnologies, Santé
2026-07-29 6:00 AM EDT | Restart Life Sciences Corp.
Rapid Dose Therapeutics (DOSE) (RDTCF) and Bodhi Health Expand Distribution and Sales of CurcuWIN(R) QuickStrip(TM) Curcumin Across Canada
Burlington, Ontario--(Newsfile Corp. - July 28, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("Rapid Dose" or "RDT"), a Canadian biotechnology company, and Ontario-based Bodhi Health Inc. ("Bodhi Health") today announced an expansion of their coordinated distribution, sales and market-development efforts for Bodhi Health Sublingual Curcumin, manufactured using Rapid Dose's proprietary QuickStrip™ oral thin-film technology and the patented CurcuWIN® curcumin form
2026-07-28 4:05 PM EDT | Rapid Dose Therapeutics Corp.
Hemostemix' Longevity Phase I Clinical Trial Leveraging VesCell(TM)'s Excellent Results
Calgary, Alberta--(Newsfile Corp. - July 28, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"), an autologous (patient's own stem cells) regenerative medicine company is pleased to announce the VesCell™ Phase I Longevity Clinical Trial protocol has been drafted. The longevity protocol represents an important milestone in Hemostemix's strategy to expand the clinical application of VesCell™ beyond the treatment of card
Biotechnologies, Pharmaceutique, Santé
2026-07-28 12:14 PM EDT | Hemostemix Inc.
AAMI Surveys Cardiac Health Professionals on Battery Longevity Management of Pacemakers
Arlington, Virginia--(Newsfile Corp. - July 28, 2026) - The Association for the Advancement of Medical Instrumentation (AAMI) officially announces the publication of a new guidance document on battery longevity management for implantable cardiac pacemakers and related devices. Given the limits of existing industry standards for cardiovascular implantable electronic device safety, there is significant variation among devices
2026-07-28 8:50 AM EDT | Association for the Advancement of Medical Instrumentation
George E. Norcross III to Donate $100 Million to Cooper University Health Care/MD Anderson Cancer Center at Cooper in Honor of His Parents, George E. Norcross Jr. and Anne Carol Conner Norcross
Camden, New Jersey--(Newsfile Corp. - July 28, 2026) - Cooper University Health Care Board of Trustees Executive Chairman, Co-President and Co-Chief Executive Officer Anthony J. Mazzarelli, MD, and the Board of Trustees today announced a transformational $100 million
2026-07-28 8:00 AM EDT | Cooper University Health Care
Apptly's UberDoc Partners with Bryleos, Bringing Woman-Owned Cellular-Health Innovator onto the Marketplace
Vancouver, British Columbia--(Newsfile Corp. - July 28, 2026) - Apptly Health Technologies Corp. (CSE: APPT) (FSE: 4KL0) (the "the Company" or "Apptly"), operator of the UberDoc direct-pay healthcare marketplace, today announced a strategic partnership with Bryleos (BioNADrx Holdings, Inc.), a woman-owned life sciences company focused on NAD+ science and oral cellular-health formulations. Highlights: Marketplace Onboarding: Bryleos joins the
2026-07-28 8:00 AM EDT | Apptly Health Technologies Corp.
BioHarvest Sciences to Report Second Quarter 2026 Financial Results on August 11, 2026
British Columbia and Rehovot, Israel--(Newsfile Corp. - July 28, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that it will report its second quarter 2026 financial results before the market opening on Tuesday, August 11, 2026. The Company will host a conference call and webcast at 8:00 AM Eastern Time to discuss the r
Biotechnologies, Pharmaceutique, Santé
2026-07-28 8:00 AM EDT | BioHarvest Sciences Inc.
NuGen Adds to Core Patent Portfolio for Future Needle-Free Platforms
Toronto, Ontario--(Newsfile Corp. - July 27, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free drug delivery, today announced the filing of two additional patent applications supporting its current patent portfolio. The new applications focus on high-efficiency spring charging technology and automatic dose-establishment technology. Together with previously announced patent applications relating to the Company's dual-spring
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-07-27 5:15 PM EDT | NuGen Medical Devices Inc.
PreveCeutical Closes Third Tranche of Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - July 27, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases dated June 12, 2026, May 12, 2026 and April 22, 2026, it has closed a third tranche (the "Third Tranche") of its previously announced non-brokered private placement (the "Offering"), which Third Tranche consisted of the issuance of 8,0
Biotechnologies, Pharmaceutique, Santé
2026-07-27 5:12 PM EDT | PreveCeutical Medical Inc.